AMGEN INC — Director's Dealing 2012

Mar 6, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MICROMET, INC. (MITI)
CIK: 0001131907
Period of Report: 2012-03-02

Reporting Person: AMGEN INC (10% Owner)
Reporting Person: Armstrong Acquisition Corp. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	80025097	Indirect

Footnotes

F1: In accordance with the Agreement and Plan of Merger, dated January 25, 2012, by and among Amgen Inc., a Delaware corporation ("Amgen"), Armstrong Acquisition Corp., a Delaware corporation ("Purchaser") and wholly-owned subsidiary of Amgen, and Micromet, Inc., a Delaware corporation ("Micromet"), Purchaser commenced a tender offer (the "Offer") to acquire all of the outstanding shares of common stock, par value $0.00004 per share (together with the associated preferred share purchase rights, the "Shares"), of Micromet at a purchase price of $11.00 per Share in cash, without interest, less any applicable withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated February 2, 2012, and the related Letter of Transmittal, included as exhibits to the Tender Offer Statement on Schedule TO-T filed by Purchaser and Amgen with the Securities and Exchange Commission on February 2, 2012.

F2: The Offer expired at 12:00 midnight, New York City time, at the end of Thursday, March 1, 2012 (the "Expiration Date"). Based on the information provided to Amgen by the depositary of the Offer, as of the Expiration Date, a total of approximately 80,025,097 Shares (excluding 3,150,586 Shares subject to guaranteed delivery procedures as described in the Offer to Purchase) were validly tendered and not validly withdrawn, representing approximately 83.95% of the Shares then outstanding. On Friday, March 2, 2012, Purchaser accepted for payment all Shares validly tendered and not validly withdrawn.